Prevalence and Risk Factors of QTc Prolongation in Prostate Cancer Patients Undergoing Brachytherapy.

Aged Androgen Antagonists / therapeutic use Brachytherapy / adverse effects Humans Long QT Syndrome / epidemiology Male Middle Aged Prostatic Neoplasms / blood Retrospective Studies Risk Factors Testosterone / blood
Prostate cancer QTc prolongation androgen deprivation therapy brachytherapy

Journal

Cancer investigation
ISSN: 1532-4192
Titre abrégé: Cancer Invest
Pays: England
ID NLM: 8307154

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 11 1 2022
medline: 22 2 2022
entrez: 10 1 2022
Statut: ppublish

Résumé

QTc prolongation is linked to Torsade de Pointes, sudden cardiac death, and overall cardiovascular mortality. 754 prostate cancer patients undergoing brachytherapy were analyzed, prolonged QTc was defined as ≥450ms. A prolonged QTc was more frequent (10.1 vs. 5.1%,

Identifiants

DOI: 10.1080/07357907.2022.2027435 PMID: 35000504
pubmed: 35000504
doi: 10.1080/07357907.2022.2027435
doi:

Substances chimiques

Androgen Antagonists 0
Testosterone 3XMK78S47O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-227

Auteurs

Simon Saad (S)

Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
ORCID: 0000-0003-0066-5072

Guila Delouya (G)

Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
CRCHUM-Centre de Recherche du Centre Hospitalier, de l'Université de Montréal, Montreal, Canada.

Carole Lambert (C)

Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
CRCHUM-Centre de Recherche du Centre Hospitalier, de l'Université de Montréal, Montreal, Canada.

Maroie Barkati (M)

Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
CRCHUM-Centre de Recherche du Centre Hospitalier, de l'Université de Montréal, Montreal, Canada.

Charles Dariane (C)

Department of Urology, University of Montreal Health Center, Montreal, Canada.
Department of Urology, Hôpital européen Georges-Pompidou, Paris University, Paris, France.

Mikhael Laskine (M)

CRCHUM-Centre de Recherche du Centre Hospitalier, de l'Université de Montréal, Montreal, Canada.
Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Daniel Taussky (D)

Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
CRCHUM-Centre de Recherche du Centre Hospitalier, de l'Université de Montréal, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Antihormones › Antagonistes des androgènes › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Curiethérapie › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Syndrome du QT long › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Prevalence and Risk Factors of QTc...
questionsmedicales.fr › Hormones gonadiques › Hormones sexuelles stéroïdiennes › Congénères de la testostérone › Testostérone › Prevalence and Risk Factors of QTc...